Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma (Q36822182)
Jump to navigation
Jump to search
scientific article published on 28 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma |
scientific article published on 28 December 2010 |
Statements
1 reference
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma (English)
1 reference
Manish A Shah
1 reference
Minaxi Jhawer
1 reference
David H Ilson
1 reference
Robert A Lefkowitz
1 reference
Edric Robinson
1 reference
Marinela Capanu
1 reference
David P Kelsen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference